Geneva-based Spineart and Vaud-based Distalmotion have each cleared a new regulatory hurdle for their surgical technologies. Spineart has received U.S. Food and Drug Administration (FDA) approval for ...

Indivi is a Basel-based TechBio company advancing precision neuroscience to accelerate the development of novel therapeutics. Neurodegenerative disease trials suffer high failure rates, particularly ...

The shareholders of Swiss sovereign cloud provider Infomaniak have signed an agreement for the listing of the company on the SIX Swiss Exchange, through a reverse takeover transaction with Perrot ...

Oculis is a biopharmaceutical company focused on neuro-ophthalmology and ophthalmology. Its late-stage clinical pipeline focuses on two core product candidates. Privosegtor and Licaminlimab.

Ensysce Biosciences, a clinical-stage company developing a new class of highly novel opioids for the treatment of severe pain, has acquired Zug-based Cy Biopharma, a clinical-stage biotechnology ...

Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY scientific software into its agentic AI workflows. Bruker acquired ...

The Swiss-Indian agritech startup SUIND has raised around CHF 1.75 million (INR 20.5 crore) in a seed funding round led by Transition VC, with participation from IIMA Ventures. The startup will use ...

Although biotech start-ups stand out with their mega-investments, there are numerous successful start-ups in the life sciences sector centred around pharmaceuticals.

Vaud-based PeriVision, a University of Bern spin-off, has developed VisionOne, a platform that uses virtual reality glasses to measure the impact of glaucoma on visual fields – information that is ...

FGE NexantECA has completed the acquisition of Morges-based Square Commodities ("SquareCo"), the leading research and data analytics platform specialising in the global renewable fuels market. Founded ...

Das 2020 gegründete Zürcher Unternehmen Circet Schweiz übernimmt Technik Partner, einen Spezialisten für die ...

Aisot Technologies AG, das ETH-Zürich-Spin-off für KI-gestützte Portfolio-Intelligenz für institutionelle Investoren, hat eine Seed-Extension-Finanzierungsrunde über CHF 2 Millionen erfolgreich ...